Medications
Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find
Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
Jul 20, 2023
0
0
News tagged with generic manufacturers
Medications
Why your generic drugs may not be safe and the FDA may be too lax
Generic prescription drugs have saved the U.S. about US$1.7 trillion over the past decade. The Food and Drug Administration approved a record 781 new generics in 2018 alone, including generic versions of Cialis, Levitra ...
Dec 4, 2019
0
2
Medications
Price competition for generic drugs linked to increase in manufacturing-related recalls
Researchers from three universities have found that extreme price competition in the generic pharmaceutical market—designed to make medications more affordable—may be putting more patients at serious health risk, as evidenced ...
May 30, 2018
0
3
Medications
Hospitals hit back on drug pricing, but will they knock out the problem?
Drug manufacturing and pricing vaulted into the news several years ago when a privately held company raised the price of a drug used for infections from US$13.50 to $750 for one pill.
Mar 28, 2018
0
2
Medications
States seek to expand lawsuit against generic drug-makers
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as senior executives at two companies.
Oct 31, 2017
0
0
Medications
Why are some generic drugs getting so expensive?
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in the retail sector, ...
Jan 21, 2015
0
13
Medications
Ranbaxy taking 'stringent steps' to end US FDA ban
India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.
Sep 21, 2013
0
0
Medications
Indian drugmaker Ranbaxy faces new US regulation woes (Update 2)
Shares in Indian generic drugs giant Ranbaxy Laboratories crashed by as much as 35 percent on Monday after the US Food and Drug Administration suspended imports from one of its factories.
Sep 16, 2013
0
0
Medications
S.Africa tackles drugs patent reform
South Africa's government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs.
Sep 9, 2013
0
0
Medications
US court rules to protect generic drug makers
Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday.
Jun 24, 2013
0
0
